Page last updated: 2024-11-13

gallidermin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

gallidermin: lanthionine-containing peptide antibiotic (lantibiotic); from Staphylococcus gallinarum; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID156963389
MeSH IDM0161198

Synonyms (1)

Synonym
gallidermin

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Melittin, while showing little potential as an antimicrobial agent, may have potential in delivery of poorly bioavailable drugs."( Investigation of the cytotoxicity of eukaryotic and prokaryotic antimicrobial peptides in intestinal epithelial cells in vitro.
Maher, S; McClean, S, 2006
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (45)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (4.44)18.7374
1990's12 (26.67)18.2507
2000's11 (24.44)29.6817
2010's18 (40.00)24.3611
2020's2 (4.44)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (4.26%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other45 (95.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]